Joshua C Magee1, Daniel F Lewis2, Theresa Winhusen2. 1. Department of Family and Community Medicine, University of Cincinnati College of Medicine, Cincinnati, OH; joshuacmagee@gmail.com. 2. Department of Psychiatry and Behavioral Neuroscience, Addiction Sciences Division, University of Cincinnati College of Medicine, Cincinnati, OH.
Abstract
INTRODUCTION: Smoking is highly prevalent in substance dependence, but smoking-cessation treatment (SCT) is more challenging in this population. To increase the success of smoking cessation services, it is important to understand potential therapeutic targets like nicotine craving that have meaningful but highly variable relationships with smoking outcomes. This study characterized the presence, magnitude, and specificity of nicotine craving as a mediator of the relationship between SCT and smoking abstinence in the context of stimulant-dependence treatment. METHODS: This study was a secondary analysis of a randomized, 10-week trial conducted at 12 outpatient SUD treatment programs. Adults with cocaine and/or methamphetamine dependence (N = 538) were randomized to SUD treatment as usual (TAU) or TAU+SCT. Participants reported nicotine craving, nicotine withdrawal symptoms, and substance use in the week following a uniform quit attempt of the TAU+SCT group, and self-reported smoking 7-day point prevalence abstinence (verified by carbon monoxide) at end-of-treatment. RESULTS: Bootstrapped regression models indicated that, as expected, nicotine craving following a quit attempt mediated the relationship between SCT and end-of-treatment smoking point prevalence abstinence (mediation effect = 0.09, 95% CI = 0.04% to 0.14%, P < .05, 14% of total effect). Nicotine withdrawal symptoms and substance use were not significant mediators (Ps > .05, <1% of total effect). This pattern held for separate examinations of cocaine and methamphetamine dependence. CONCLUSIONS: Nicotine craving accounts for a small but meaningful portion of the relationship between smoking-cessation treatment and smoking abstinence during SUD treatment. Nicotine craving following a quit attempt may be a useful therapeutic target for increasing the effectiveness of smoking-cessation treatment in substance dependence.
RCT Entities:
INTRODUCTION: Smoking is highly prevalent in substance dependence, but smoking-cessation treatment (SCT) is more challenging in this population. To increase the success of smoking cessation services, it is important to understand potential therapeutic targets like nicotine craving that have meaningful but highly variable relationships with smoking outcomes. This study characterized the presence, magnitude, and specificity of nicotine craving as a mediator of the relationship between SCT and smoking abstinence in the context of stimulant-dependence treatment. METHODS: This study was a secondary analysis of a randomized, 10-week trial conducted at 12 outpatient SUD treatment programs. Adults with cocaine and/or methamphetamine dependence (N = 538) were randomized to SUD treatment as usual (TAU) or TAU+SCT. Participants reported nicotine craving, nicotine withdrawal symptoms, and substance use in the week following a uniform quit attempt of the TAU+SCT group, and self-reported smoking 7-day point prevalence abstinence (verified by carbon monoxide) at end-of-treatment. RESULTS: Bootstrapped regression models indicated that, as expected, nicotine craving following a quit attempt mediated the relationship between SCT and end-of-treatment smoking point prevalence abstinence (mediation effect = 0.09, 95% CI = 0.04% to 0.14%, P < .05, 14% of total effect). Nicotine withdrawal symptoms and substance use were not significant mediators (Ps > .05, <1% of total effect). This pattern held for separate examinations of cocaine and methamphetamine dependence. CONCLUSIONS:Nicotine craving accounts for a small but meaningful portion of the relationship between smoking-cessation treatment and smoking abstinence during SUD treatment. Nicotine craving following a quit attempt may be a useful therapeutic target for increasing the effectiveness of smoking-cessation treatment in substance dependence.
Authors: Jed E Rose; Lisa H Brauer; Frederique M Behm; Matthew Cramblett; Kevin Calkins; Dawn Lawhon Journal: Alcohol Clin Exp Res Date: 2002-12 Impact factor: 3.455
Authors: Ashwin A Patkar; Paolo Mannelli; Kathleen Peindl; Heather W Murray; Bradley Meier; Frank T Leone Journal: Am J Drug Alcohol Abuse Date: 2006 Impact factor: 3.829
Authors: Ralph Spiga; Margaret P Martinetti; Richard A Meisch; Katherine Cowan; Steven Hursh Journal: Psychopharmacology (Berl) Date: 2004-10-30 Impact factor: 4.530
Authors: Sean X Luo; Melanie Wall; Lirio Covey; Mei-Chen Hu; Jennifer M Scodes; Frances R Levin; Edward V Nunes; Theresa Winhusen Journal: Am J Drug Alcohol Abuse Date: 2018-01-25 Impact factor: 3.829
Authors: William S John; He Zhu; Paolo Mannelli; Robert P Schwartz; Geetha A Subramaniam; Li-Tzy Wu Journal: Drug Alcohol Depend Date: 2018-03-27 Impact factor: 4.492
Authors: Nayoung Kim; Danielle E McCarthy; Jessica W Cook; Megan E Piper; Tanya R Schlam; Timothy B Baker Journal: Addiction Date: 2020-10-01 Impact factor: 6.526